Journal of Renal Nutrition
Volume 17, Issue 2 , Pages 126-131, March 2007

Effects of Omega-3 Fatty Acid Supplementation on Vascular Access Thrombosis in Polytetrafluorethylene Grafts

  • Rodney G. Bowden, PhD

      Affiliations

    • Department of Health, Human Performance, and Recreation, Center for Exercise, Nutrition, and Preventive Health Research, Baylor University
    • Corresponding Author InformationAddress reprint requests to Rodney G. Bowden, PhD, Department of Health, Human Performance, and Recreation, Center for Exercise, Nutrition, and Preventive Health Research, Baylor University, One Bear Place No. 97313, Waco, TX 76798-7313, USA.
  • ,
  • Ronald L. Wilson, MD

      Affiliations

    • Central Texas Nephrology Associates
  • ,
  • Mindy Gentile, MS, RD, LD

      Affiliations

    • Brazos Kidney Center, Waco, Texas.
  • ,
  • Songthip Ounpraseuth, MS

      Affiliations

    • Department of Health, Human Performance, and Recreation, Center for Exercise, Nutrition, and Preventive Health Research, Baylor University
  • ,
  • Page Moore, MS

      Affiliations

    • Department of Health, Human Performance, and Recreation, Center for Exercise, Nutrition, and Preventive Health Research, Baylor University
  • ,
  • Brian C. Leutholtz, PhD

      Affiliations

    • Department of Health, Human Performance, and Recreation, Center for Exercise, Nutrition, and Preventive Health Research, Baylor University

Objective

The purpose of this study was to investigate the effects of orally administered over-the-counter omega-3 (n-3) fatty acid supplements on primary patency of polytetrafluoroethylene (PTFE) grafts.

Design

This study was conducted with a triple-blind, permuted-block, randomized, placebo-controlled experimental design.

Setting

Dialysis clinics with patients who, in accordance with physician diagnosis, needed a new PTFE graft.

Patients and Other Participants

Patients on long-term hemodialysis with newly placed PTFE grafts who were unable to receive a native arteriovenous fistula.

Intervention

Patients were followed prospectively for 8 months after they had been placed into an n-3 fatty acid or control group and were monitored for primary patency.

Main Outcome Variable

Primary patency of the PTFE graft.

Results

The n-3 fatty acid group had a mean PTFE graft primary patency rate of 254.2 days (SEM = 51.8), and the control group had a mean PTFE graft primary patency rate of 254.1 days (SEM = 34.6), revealing no significant difference in survival time between groups.

Conclusions

No significant differences in primary patency rates were noted in the experimental and control groups.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Data were collected in clinics associated with Central Texas Nephrology Associates.

PII: S1051-2276(06)00163-4

doi:10.1053/j.jrn.2006.07.009

Journal of Renal Nutrition
Volume 17, Issue 2 , Pages 126-131, March 2007